Caxton Associates (New York)’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-202,157
Closed -$708K 580
2024
Q2
$708K Buy
+202,157
New +$708K 0.02% 287